Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

Miao Wang(Ministry of Agriculture), Guojiang Mei(Shanghai University of Traditional Chinese Medicine), Yu Tian(Sichuan University), Xinwei Peng(Fudan University), Zhijie Zhang(Huazhong University of Science and Technology), Ke Li(Hong Kong Polytechnic University), Feng Li(Guangzhou Eighth People's Hospital), Jie Hong(Changchun University of Science and Technology), Wei Lu(Shanghai University of Traditional Chinese Medicine), Shi Jin(Fudan University), Zengliang Wang(Shandong University), Kepei Zhang(Shanghai University of Traditional Chinese Medicine)
Infection and Drug Resistance
March 1, 2023
10.2147/idr.s389883
Cited by 3

Related Papers

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|536
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
AAV-ie enables safe and efficient gene transfer to inner ear cells
|Nature Communications|2019|228
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
|PLoS Pathogens|2014|224
NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis
|Neuron|2023|95